tiprankstipranks
Trending News
More News >
Champions Oncology (CSBR)
NASDAQ:CSBR
US Market

Champions Oncology (CSBR) Income Statement

Compare
141 Followers

Champions Oncology Income Statement

Last quarter (Q2 2026), Champions Oncology's total revenue was $15.04M, an increase of 11.46% from the same quarter last year. In Q2, Champions Oncology's net income was $299.00K. See Champions Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 56.94M$ 50.16M$ 53.87M$ 49.11M$ 41.04M
Gross Profit
$ 26.91M$ 20.75M$ 24.34M$ 25.48M$ 19.59M
Operating Expenses
$ 22.07M$ 27.68M$ 28.79M$ 24.87M$ 19.23M
Depreciation and Amortization
$ 1.64M$ 1.87M$ 3.20M$ 2.41M$ 1.58M
EBITDA
$ 6.29M$ -5.41M$ -2.07M$ 3.00M$ 2.02M
Operating Income
$ 4.85M$ -6.92M$ -4.45M$ 607.00K$ 366.00K
Other Income/Expenses
$ -220.00K$ -387.00K$ -818.00K$ -24.00K$ 71.00K
Pretax Income
$ 4.63M$ -7.31M$ -5.27M$ 583.00K$ 437.00K
Net Income
$ 4.70M$ -7.28M$ -5.33M$ 548.00K$ 362.00K
Per Share Metrics
Basic EPS
$ 0.34$ -0.54$ -0.39$ 0.04$ 0.03
Diluted EPS
$ 0.33$ -0.54$ -0.39$ 0.04$ 0.02
Weighted Average Shares Outstanding
13.66M 13.55M 13.54M 13.20M 13.14M
Weighted Average Shares Outstanding (Diluted)
14.27M 13.55M 13.54M 14.16M 14.57M
Currency in USD

Champions Oncology Earnings and Revenue History